IdentificationGeneric Name(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanolDrugBank Accession NumberDB07504BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol (DB07504)× CloseWeightAverage: 458.352 Monoisotopic: 457.111337684 Chemical FormulaC21H24BrN5O2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUCyclin-dependent kinase 2Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableClassificationNot classifiedAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyMEIJADBULOETOV-QGZVFWFLSA-NInChIInChI=1S/C21H24BrN5O2/c1-27(2)13-17(28)14-29-18-10-8-16(9-11-18)25-21-23-12-19(22)20(26-21)24-15-6-4-3-5-7-15/h3-12,17,28H,13-14H2,1-2H3,(H2,23,24,25,26)/t17-/m1/s1IUPAC Name(2R)-1-(4-{[5-bromo-6-(phenylimino)-1,6-dihydropyrimidin-2-yl]amino}phenoxy)-3-(dimethylamino)propan-2-olSMILES[H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=NC=C(Br)C(=N1)N([H])C1=CC=CC=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound445957PubChem Substance99443975ChemSpider393437ZINCZINC000000589075PDBe LigandBYPPDB Entries1h08Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.035 mg/mLALOGPSlogP3.83ALOGPSlogP3.23ChemaxonlogS-4.1ALOGPSpKa (Strongest Acidic)9.13ChemaxonpKa (Strongest Basic)8.65ChemaxonPhysiological Charge2ChemaxonHydrogen Acceptor Count7ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area81.48 Å2ChemaxonRotatable Bond Count8ChemaxonRefractivity121.28 m3·mol-1ChemaxonPolarizability46.32 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9559Blood Brain Barrier-0.5576Caco-2 permeable+0.5135P-glycoprotein substrateSubstrate0.6789P-glycoprotein inhibitor INon-inhibitor0.5869P-glycoprotein inhibitor IIInhibitor0.9298Renal organic cation transporterNon-inhibitor0.7383CYP450 2C9 substrateNon-substrate0.8529CYP450 2D6 substrateNon-substrate0.7957CYP450 3A4 substrateSubstrate0.5236CYP450 1A2 substrateInhibitor0.5432CYP450 2C9 inhibitorNon-inhibitor0.722CYP450 2D6 inhibitorNon-inhibitor0.5314CYP450 2C19 inhibitorNon-inhibitor0.6006CYP450 3A4 inhibitorNon-inhibitor0.7024CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.6201Ames testNon AMES toxic0.636CarcinogenicityNon-carcinogens0.8816BiodegradationNot ready biodegradable1.0Rat acute toxicity2.3669 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.8155hERG inhibition (predictor II)Inhibitor0.6061  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Cyclin-dependent kinase 2KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionMetal ion bindingSpecific FunctionSerine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, N...Gene NameCDK2Uniprot IDP24941Uniprot NameCyclin-dependent kinase 2Molecular Weight33929.215 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:23 / Updated at June 12, 2020 16:52 